Last10K.com

Acro Biomedical Co., Ltd. (ACBM) SEC Filing 8-K Material Event for the period ending Monday, January 13, 2020

Acro Biomedical Co., Ltd.

HISTORY TOOLS
CIK: 1622996 Ticker: ACBM

View differences made from one to another to evaluate Acro Biomedical Co., Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acro Biomedical Co., Ltd..

Continue

Assess how Acro Biomedical Co., Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ACBM
CIK: 1622996
Form Type: 8-K Corporate News
Accession Number: 0001640334-20-000108
Submitted to the SEC: Fri Jan 17 2020 10:32:00 AM EST
Accepted by the SEC: Fri Jan 17 2020
Period: Monday, January 13, 2020
Industry: Amusement And Recreation Services
Events:
  1. Bylaw Change

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/acbm/0001640334-20-000108.htm